Alnylam Pharmaceuticals, Inc. (LON: 0HD2)

Alnylam Pharmaceuticals Revenue

Alnylam Pharmaceuticals had revenue of $500.92M USD in the quarter ending September 30, 2024, a decrease of -33.26%. This brings the company's revenue in the last twelve months to $2.09B, up 21.54% year-over-year. In the year 2023, Alnylam Pharmaceuticals had annual revenue of $1.83B with 76.23% growth.

• Revenue (ttm): $2.09B
• Revenue Growth: +21.54%
• P/S Ratio: n/a
• Revenue / Employee: $997.52K
• Employees: 2,100
• Market Cap: 28.15B GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.83B	790.87M	76.23%
Dec 31, 2022	1.04B	193.13M	22.88%
Dec 31, 2021	844.29M	351.43M	71.31%
Dec 31, 2020	492.85M	273.10M	124.28%
Dec 31, 2019	219.75M	144.84M	193.36%